Healthcare Modeling Part 3: Cost Effectiveness of Personalized Medicine

Venue: Complimentary online conference

Location: Toronto, Canada

Event Date/Time: Sep 22, 2009 End Date/Time: Sep 22, 2010
Report as Spam


Personalized medicine has attracted a great deal of attention from payers in recent years. The underlying premise of personalized medicine is the use of genetic information to ensure that new and existing medical interventions are used more effectively and more safely. This will help to deliver medications to the right patient, at the right dose, at the right time while minimizing side effects. However, as a new healthcare technology, it is important to quantify the impact of genetic testing/screening on both clinical and economic outcomes and to demonstrate the overall benefit of personalized medicine in comparison to standard treatment.

In this webinar Peter Alperin, M.D., Medical Director at Archimedes, Inc., will explain the Archimedes Model - a scientifically and clinically validated mathematical model that has been in development for over 15 years, and how to use the Archimedes Model to evaluate cost-effectiveness of genetic testing/screening.

The participant will leave the presentation:

* Understanding, in general terms, how the Archimedes Model works
* Understanding how the Archimedes model enables you to deliver substantial value to your organization by more accurately answering critical question about efficacy, costs, and target markets
* Understanding how the Archimedes model enables you to conduct simulations of real-world settings to distinguish your product’s clinical and economic benefits from your competition with regards to specific target (sub) populations.